Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Oncology | Nephrology | Family Medicine

Bladder Cancer Clinical Trials

A listing of Bladder Cancer medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter by:

Phase:

Gender:

Age:

Location:

 

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic email notifications as soon as a clinical trial is posted in the medical category you're interested in.


First 1 2 3 4 Last 

Alabama

University of Alabama Hematology Oncology Clinic at Medical West
Birmingham Alabama 35294
Updated

A clinical trial to evaluate treatments using OGX-427 and Docetaxel for patients with Bladder Cancer or Urothelial Carcinoma

Arizona

Mayo Clinic Hospital
Phoenix Arizona 85054

Patients are needed to participate in a clinical research study evaluating DN24-02 and Standard of Care for the treatment of Urothelial Carcinoma

BCG Oncology
Phoenix Arizona 85032

Patients are needed to participate in a clinical research study of TMX-101 to evaluate Carcinoma in Situ or Non Muscle Invasive Bladder Cancer

Mayo Clinic Arizona
Scottsdale Arizona 85259

Patients are needed to participate in a clinical research study evaluating DN24-02 and Standard of Care for the treatment of Urothelial Carcinoma

California

City of Hope
Duarte California 91010
Updated

A clinical trial to evaluate treatments using OGX-427 and Docetaxel for patients with Bladder Cancer or Urothelial Carcinoma

City of Hope Medical Center
Duarte California 91010

Patients are needed to participate in a clinical research study evaluating DN24-02 and Standard of Care for the treatment of Urothelial Carcinoma

USC/Norris Comprehensive Cancer Center
Los Angeles California 90033

Patients are needed to participate in a clinical research study evaluating DN24-02 and Standard of Care for the treatment of Urothelial Carcinoma

VA Palo Alto Health Care System
Palo Alto California 94304

A clinical trial seeking patients for a research study for the treatment of Bladder Cancer

Genesis Research
San Diego California 92123

Patients are needed to participate in a clinical research study evaluating DN24-02 and Standard of Care for the treatment of Urothelial Carcinoma

View More »

Stanford University School of Medicine
Stanford California 94305

A clinical trial seeking patients for a research study of Pazopanib (GW786034) and Paclitaxel

Stanford University Hospital
Stanford California 94305

Patients are needed to participate in a clinical research study evaluating DN24-02 and Standard of Care for the treatment of Urothelial Carcinoma

Colorado

The Urology Center of Colorado
Denver Colorado 80211

Phase 2, randomized, open label, parallel ARM study to evaluate the safety and efficacy of rAd-IFN/Syn 3 following intravesical administration in subjects with high grade, BCG refractory or relapsed non-muscle invasive bladder cancer.

The Urology Center of Colorado
Denver Colorado 80211

Phase II Pilot Study with TMX-101 in Patients with Carcinoma in Situ (CIS) Bladder Cancer

The Urology Center of Colorado
Denver Colorado 80211

Phase II, open-label study evaluating DN24-02 as adjuvant therapy in subjects with high risk HER2+ urothelial carcinoma.

View More »

University of Colorado, Anschutz Cancer Pavilion
Aurora Colorado 80045

Patients are needed to participate in a clinical research study evaluating DN24-02 and Standard of Care for the treatment of Urothelial Carcinoma

The Urology Center of Colorado
Denver Colorado 80211

Patients are needed to participate in a clinical research study evaluating DN24-02 and Standard of Care for the treatment of Urothelial Carcinoma

The Urology Center of Colorado
Denver Colorado 80211

Patients are needed to participate in a clinical research study of TMX-101 to evaluate Carcinoma in Situ or Non Muscle Invasive Bladder Cancer

Connecticut

Neag Comprehensive Cancer Center/University of Connecticut Health Center
Farmington Connecticut 06030

Patients are needed to participate in a clinical research study evaluating DN24-02 and Standard of Care for the treatment of Urothelial Carcinoma

Florida

Urological Research Network
Hialeah Florida 33016

Patients are needed to participate in a clinical research study evaluating DN24-02 and Standard of Care for the treatment of Urothelial Carcinoma

University of Miami Miller School of Medicine
Miami Florida 33136

A Phase 1/Phase 2 clinical study for patients with Urothelial Carcinoma

University of Miami Cancer Center
Miami Florida 33136

Patients are needed to participate in a clinical research study evaluating DN24-02 and Standard of Care for the treatment of Urothelial Carcinoma

MD Anderson Cancer Center Orlando
Orlando Florida 32806

A Phase 1/Phase 2 clinical study for patients with Non-muscle Invasive Bladder Cancer

M.D. Anderson Cancer Center Orlando
Orlando Florida 32806

Patients are needed to participate in a clinical research study of Cisplatin, Gemcitabine and ALT-801 to evaluate Transitional Cell Carcinoma of Bladder, Urethra Cancer, Ureter Cancer or Malignant Tumor of Renal Pelvis

View More »

Martin Health System
Stuart Florida 34994

A Phase 1/Phase 2 clinical study for patients with Non-muscle Invasive Bladder Cancer

Martin Health System
Stuart Florida 34994

Patients are needed to participate in a clinical research study of Cisplatin, Gemcitabine and ALT-801 to evaluate Transitional Cell Carcinoma of Bladder, Urethra Cancer, Ureter Cancer or Malignant Tumor of Renal Pelvis

H. Lee Moffitt Cancer Center and Research Institute
Tampa Florida 33612

A clinical trial seeking patients for a research study for the treatment of Bladder Cancer

H. Lee Moffitt Cancer Center & Research Institute, Inc.
Tampa Florida 33612

Patients are needed to participate in a clinical research study evaluating DN24-02 and Standard of Care for the treatment of Urothelial Carcinoma

H. Lee Moffitt Cancer Center and Research Institute
Tampa Florida 33612

Patients are needed to participate in a clinical research study of Cisplatin, Gemcitabine and ALT-801 to evaluate Transitional Cell Carcinoma of Bladder, Urethra Cancer, Ureter Cancer or Malignant Tumor of Renal Pelvis

Georgia

Emory University Department of Urology
Atlanta Georgia 30322
Updated

A clinical research study of Monopolar electrocautery loop in Transurethral resection of bladder tumors and PK Button Vaporization Electrode in transurethral resection of bladder tumors for the treatment of Bladder Cancer

The Emory Clinic
Atlanta Georgia 30322

Hexvix Cystoscopy for Detection of Bladder Cancer

Emory University
Atlanta Georgia 30322

Patients are needed to participate in a clinical research study of Cisplatin, Gemcitabine and ALT-801 to evaluate Transitional Cell Carcinoma of Bladder, Urethra Cancer, Ureter Cancer or Malignant Tumor of Renal Pelvis

Illinois

University of Chicago Medical Center
Chicago Illinois 60637

Patients are needed to participate in a clinical research study evaluating DN24-02 and Standard of Care for the treatment of Urothelial Carcinoma

The University of Chicago
Chicago Illinois 60637

Patients are needed to participate in a clinical research study evaluating Neo-Urinary Conduit for the treatment of Bladder Cancer

Robert Lurie Comprehensive Cancer Center of Northwestern University
Chicago Illinois 60611

Patients are needed to participate in a clinical research study of Cisplatin, Gemcitabine and ALT-801 to evaluate Transitional Cell Carcinoma of Bladder, Urethra Cancer, Ureter Cancer or Malignant Tumor of Renal Pelvis

Indiana

IU Health Goshen Hospital
Goshen Indiana 46527
Updated

A clinical trial to evaluate treatments using OGX-427 and Docetaxel for patients with Bladder Cancer or Urothelial Carcinoma

Indiana University Simon Cancer Center
Indianapolis Indiana 46202

A clinical trial to evaluate treatments using Amrubicin for patients with Bladder Cancer

Indiana University Melvin and Bren Simon Cancer Center
Indianapolis Indiana 46202

A clinical trial to evaluate treatments using Dovitinib for patients with Bladder Cancer

IU Health Central Indiana Cancer Centers
Indianapolis Indiana 46219
Updated

A clinical trial to evaluate treatments using OGX-427 and Docetaxel for patients with Bladder Cancer or Urothelial Carcinoma

Indiana University Melvin & Bren Simon Cancer Center
Indianapolis Indiana 46202
Updated

A clinical trial to evaluate treatments using OGX-427 and Docetaxel for patients with Bladder Cancer or Urothelial Carcinoma

View More »

Indiana University
Indianapolis Indiana 46202

Patients are needed to participate in a clinical research study evaluating DN24-02 and Standard of Care for the treatment of Urothelial Carcinoma

IU Health at Ball Memorial Hospital
Muncie Indiana 47303
Updated

A clinical trial to evaluate treatments using OGX-427 and Docetaxel for patients with Bladder Cancer or Urothelial Carcinoma

Iowa

University of Iowa Hospitals and Clinics
Iowa City Iowa 52242

Patients are needed to participate in a clinical research study of Cisplatin, Gemcitabine and ALT-801 to evaluate Transitional Cell Carcinoma of Bladder, Urethra Cancer, Ureter Cancer or Malignant Tumor of Renal Pelvis

Kansas

University of Kansas Cancer Center
Fairway Kansas 66205

Patients are needed to participate in a clinical research study of Cisplatin, Gemcitabine and ALT-801 to evaluate Transitional Cell Carcinoma of Bladder, Urethra Cancer, Ureter Cancer or Malignant Tumor of Renal Pelvis

Kansas City Urology Care
Overland Park Kansas 66211

Patients are needed to participate in a clinical research study evaluating DN24-02 and Standard of Care for the treatment of Urothelial Carcinoma

University of Kansas Cancer Center
Westwood Kansas 66205

Patients are needed to participate in a clinical research study evaluating DN24-02 and Standard of Care for the treatment of Urothelial Carcinoma

Maryland

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Baltimore Maryland 21231

Patients are needed to participate in a clinical research study evaluating DN24-02 and Standard of Care for the treatment of Urothelial Carcinoma

Johns Hopkins Hospital
Baltimore Maryland 21287

Patients are needed to participate in a clinical research study evaluating DN24-02 and Standard of Care for the treatment of Urothelial Carcinoma

The Johns Hopkins Medical Institutions
Baltimore Maryland 21287

Patients are needed to participate in a clinical research study evaluating Neo-Urinary Conduit for the treatment of Bladder Cancer

National Cancer Institute
Bethesda Maryland 20892

Patients are needed to participate in a clinical research study evaluating Lenalidomide for the treatment of Metastatic Urothelial Carcinoma

Massachusetts

Dana Farber Cancer Institute
Boston Massachusetts 02215

A clinical trial to evaluate treatments using MGA271 for patients

First 1 2 3 4 Last